At a glance
ClinicalIndex Comparison RecordN/ACompleted· 171 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Psoriatic Arthritis Research Collaborative: Biologic Sub-Study
In Brief
An observational study for Psoriatic Arthritis. Completed, enrolled 171 participants across 4 sites.
Detailed Summary
Psoriatic arthritis (PsA) is an inflammatory arthritis with substantial variation in clinical features. We propose a multicenter collaborative approach to better understand the phenotypes and current management of PsA in the United States.The central goal of this proposal is to obtain the data necessary to design a pragmatic trial in PsA.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriatic Arthritis
CountriesUnited States
CollaboratorsThe Cleveland Clinic, NYU Langone Health, University of Utah
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 2017
Enrollment StartDec 2017
Primary CompletionAug 2023
TodayJul 2026
First PostedDec 19, 2017
Enrollment StartDec 31, 2017
Primary CompletionAug 16, 2023
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 8.5 years ago